Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI

Nature Reviews Cardiology

Volumn 13, Issue 5, 2016, Pages 276-285

  Danson, Edward ^a   Hansen, Peter ^b   Sen, Sayan ^c   Davies, Justin ^c   Meredith, Ian ^d   Bhindi, Ravinay ^b  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; AORTA STENOSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY PRESSURE; CORONARY ARTERY RECANALIZATION; FLOW MEASUREMENT; FUNCTIONAL ASSESSMENT; HEART CYCLE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; INTRACORONARY PRESSURE GUIDE WIRE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; COMORBIDITY; CORONARY ANGIOGRAPHY; DIAGNOSTIC IMAGING; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84957812838     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2016.9     Document Type: Review

References (73)

1. Stefanini, G. G., Stortecky, S., Wenaweser, P., & Windecker, S. Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat. EuroIntervention 10, U69-U75 (2014
2. Khawaja, M. Z., Redwood, S. R., & Thomas, M. Coronary artery disease in patients undergoing TAVI-why not to treat. EuroIntervention 10, U76-U83 (2014
3. Julius, B. K., et al. Angina pectoris in patients with aortic stenosis and normal coronary arteries: mechanisms and pathophysiological concepts. Circulation 95, 892-898 (1997
4. Masson, J. B., et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter. Cardiovasc. Interv. 76, 165-173 (2010
5. Stefanini, G. G., et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation Eur. Heart J. 35, 2530-2540 (2014
6. Khawaja, M. Z., et al. The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention 11, 450-455 (2015
7. Van Mieghem, N. M., et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. JACC Cardiovasc. Interv. 6, 867-875 (2013
8. Leon, M. B., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363, 1597-1607 (2010
9. Smith, C. R., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364, 2187-2198 (2011
10. Chieffo, A., et al. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). J. Am. Coll. Cardiol. 61, 830-836 (2013
11. Abdel-Wahab, M., et al. Balloon-expandable versus self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311, 1503-1514 (2014
12. Duncan, A., et al. Long-Term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the UK Transcatheter Aortic Valve Implantation Registry. JACC Cardiovasc. Interv. 8, 645-653 (2015
13. Thielmann, M., et al. Prognostic value of preoperative cardiac troponin I in patients with non ST segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. Chest 128, 3526-3536 (2005
14. Etchells, E., Meade, M., Tomlinson, G., & Cook, D. Semi-quantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a metaanalysis. J. Vasc. Surg. 36, 534-540 (2002
15. Beach, J. M., et al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J. Am. Coll. Cardiol. 61, 837-848 (2013
16. Mullany, C. J., et al. Coronary artery disease and its management: influence on survival in patients undergoing aortic valve replacement. J. Am. Coll. Cardiol. 10, 66-72 (1987
17. Lund, O., Nielsen, T. T., Pilegaard, H. K., Magnussen, K., & Knudsen, M. A. The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J. Thorac. Cardiovasc. Surg. 100, 327-337 (1990
18. Tjang, Y. S., van Hees, Y., Korfer, R., Grobbee, D. E., & van der Heijden, G. J. Predictors of mortality after aortic valve replacement. Eur. J. Cardiothorac. Surg. 32, 469-474 (2007
19. Likosky, D. S., et al. Long-Term survival of the very elderly undergoing aortic valve surgery. Circulation 120, S127-S133 (2009
20. Iung, B., et al. Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study. J. Heart Valve Dis. 2, 430-439 (1993
21. Svensson, L. G., Blackstone, E. H., & Cosgrove, D. M. 3rd Surgical options in young adults with aortic valve disease. Curr. Probl. Cardiol. 28, 417-480 (2003
22. Dewey, T. M., et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann. Thorac. Surg. 89, 758-767 (2010
23. Greason, K. L., et al. Transcatheter versus surgical aortic valve replacement in patients with prior coronary artery bypass graft operation: a PARTNER trial subgroup analysis. Ann. Thorac. Surg. 98, 1-7 (2014
24. Gilard, M., et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N. Engl. J. Med. 366, 1705-1715 (2012
25. Gautier, M., et al. Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. EuroIntervention 7, 549-555 (2011
26. Ludman, P. F., et al. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6 year follow up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation 131, 1181-1190 (2015
27. Schymik, G., et al. European experience with the second-deneration Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1 year outcomes from the SOURCE XT Registry. JACC Cardiovasc. Interv. 8, 657-669 (2015
28. Thomas, M., et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122, 62-69 (2010
29. Linke, A., et al. Treatment of aortic stenosis with a selfexpanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur. Heart J. 35, 2672-2684 (2014
30. Abdel-Wahab, M., et al. Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. Am. J. Cardiol. 109, 581-586 (2012
31. Pasic, M., et al. Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation. Interact. Cardiovasc. Thorac. Surg. 14, 463-468 (2012
32. Gasparetto, V., et al. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. Catheter. Cardiovasc. Interv. 81, 376-383 (2013
33. Abramowitz, Y., et al. Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease. Catheter. Cardiovasc. Interv. 83, 649-654 (2014
34. Griese, D. P., et al. Concomitant coronary intervention is associated with poorer early and late clinical outcomes in selected elderly patients receiving transcatheter aortic valve implantation. Eur. J. Cardiothorac. Surg. 46, e1-e7 (2014
35. Van Gameren, M., et al. Do we need separate risk stratification models for hospital mortality after heart valve surgery? Ann. Thorac. Surg. 85, 921-930 (2008
36. Pijls, N. H., et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5 year follow up of the DEFER study. J. Am. Coll. Cardiol. 49, 2105-2111 (2007
37. Tonino, P. A., et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N. Engl. J. Med. 360, 213-224 (2009
38. Prati, F., et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention 8, 823-829 (2012
39. Tu, S., et al. In vivo comparison of arterial lumen dimensions assessed by co registered three-dimensional (3D) quantitative coronary angiography, intravascular ultrasound and optical coherence tomography. Int. J. Cardiovasc. Imaging 28, 1315-1327 (2012
40. Villari, B., et al. Regression of coronary artery dimensions after successful aortic valve replacement. Circulation 85, 972-978 (1992
41. O'Sullivan, C. J., et al. Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality. JACC Cardiovasc. Interv. 8, 704-717 (2015
42. Khawaja, M. Z., Wang, D., Pocock, S., Redwood, S. R., & Thomas, M. R. The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial. Trials 15, 300 (2014
43. Takashima, H., et al. Severity of morphological lesion complexity affects fractional flow reserve in intermediate coronary stenosis. J. Cardiol. 66, 239-245 (2015
44. De Bruyne, B., et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N. Engl. J. Med. 371, 1208-1217 (2014
45. Rajappan, K., et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 105, 470-476 (2002
46. Dixon, J. A., & Spinale, F. G. Myocardial remodelling: cellular and extracellular events and targets. Annu. Rev. Physiol. 73, 47-68 (2011
47. Choudhury, L., et al. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy: a study with positron emission tomography. Eur. Heart J. 18, 108-116 (1997
48. Heusch, G. Alpha-Adrenergic coronary vasoconstriction in humans. J. Am. Coll. Cardiol. 55, 1278 (2010
49. Broyd, C. J., et al. Myocardial ischemia in aortic stenosis: insights from arterial pulse-wave dynamics after percutaneous aortic valve replacement. Trends Cardiovasc. Med. 23, 185-191 (2013
50. Galiuto, L., et al. Impaired coronary and myocardial flow in severe aortic stenosis is associated with increased apoptosis: a transthoracic Doppler and myocardial contrast echocardiography study. Heart 92, 208-212 (2006
51. Davies, J. E., et al. Arterial pulse wave dynamics after percutaneous aortic valve replacement: fall in coronary diastolic suction with increasing heart rate as a basis for angina symptoms in aortic stenosis. Circulation 124, 1565-1572 (2011
52. Stähli, B. E., Maier, W., Corti, R., Lüscher, T. F., & Altwegg, L. A. Fractional flow reserve evaluation in patients considered for transfemoral transcatheter aortic valve implantation: a case series. Cardiology 123, 234-239 (2012
53. Nijjer, S. S., et al. Improvement in coronary haemodynamics after percutaneous coronary intervention: assessment using instantaneous wave free ratio. Heart 99, 1740-1748 (2013
54. Sen, S., et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J. Am. Coll. Cardiol. 59, 1392-1402 (2012
55. Wiegerinck, E. M., et al. Impact of aortic valve stenosis on coronary hemodynamics and the instantaneous effect of transcatheter aortic valve implantation. Circ. Cardiovasc. Interv. 8, e002443 (2015
56. Davies, J. E., et al. Evidence of a dominant backward-propagating 'suction' wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy. Circulation 113, 1768-1778 (2006
57. Bountioukos, M., et al. Safety of dobutamine stress echocardiography in patients with aortic stenosis. J. Heart Valve Dis. 12, 441-446 (2003
58. Baroni, M., et al. Mechanisms of regional ischaemic changes during dipyridamole echocardiography in patients with severe aortic valve stenosis and normal coronary arteries. Heart 75, 492-497 (1996
59. Zajarias, A., Eltchaninoff, H., & Cribier, A. Successful coronary intervention after percutaneous aortic valve replacement. Catheter. Cardiovasc. Interv. 69, 522-524 (2007
60. Greenberg, G., & Kornowski, R. Coronary angioplasty after self-expandable transcatheter aortic valve implantation. J. Invasive Cardiol. 25, 361-363 (2013
61. Ribeiro, H. B., et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J. Am. Coll. Cardiol. 62, 1552-1562 (2013
62. Mohr, F. W., et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5 year follow up of the randomised, clinical SYNTAX trial. Lancet 381, 629-638 (2013
63. Adams, D. H., et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N. Engl. J. Med. 370, 1790-1798 (2014
64. Babaliaros, V., et al. 30 day outcomes from the PARTNER II trial for transapical and transfemoral 29mm TAVR in inoperable patients with the Edwards Sapien XT [abstract]. J. Am. Coll. Cardiol. 63, A1687 (2014
65. Mack, M. J., et al. 5 year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385, 2477-2484 (2015
66. Kapadia, S. R., et al. 5 year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385, 2485-2491 (2015
67. Reardon, M. J., et al. 2 year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 66, 113-121 (2015
68. Penkalla, A., et al. Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach Eur. J. Cardiothorac. Surg. 47, 1083-1089 (2015
69. Cremer, P. C., et al. Stress positron emission tomography is safe and can guide coronary revascularization in high-risk patients being considered for transcatheter aortic valve replacement. J. Nucl. Cardiol. 21, 1001-1010 (2014
70. Burgstahler, C., et al. Adenosine stress first pass perfusion for the detection of coronary artery disease in patients with aortic stenosis: a feasibility study. Int. J. Cardiovasc. Imaging 24, 195-200 (2008
71. Patsilinakos, S. P., et al. Adenosine stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. J. Nucl. Cardiol. 11, 20-25 (2004
72. Demirkol, M. O., Yaymaci, B., Debeş, H., Başaran, Y., & Turan, F. Dipyridamole myocardial perfusion tomography in patients with severe aortic stenosis. Cardiology 97, 37-42 (2002
73. Patsilinakos, S. P., et al. Detection of coronary artery disease in patients with severe aortic stenosis with noninvasive methods. Angiology 50, 309-317 (1999